Denv Envelope | List of Frontiers open access articles

Review

Published on 15 Jun 2021

Prospective Artificial Intelligence to Dissect the Dengue Immune Response and Discover Therapeutics

in B Cell Biology

Eriberto N. Natali
Lmar M. Babrak
Enkelejda Miho

Frontiers in Immunology

doi 10.3389/fimmu.2021.574411

10,706 views
18 citations

Review

Published on 20 Jul 2017

Complexity of Human Antibody Response to Dengue Virus: Implication for Vaccine Development

in Virology

Wen-Yang Tsai
Hong-En Lin
Wei-Kung Wang

Frontiers in Microbiology

doi 10.3389/fmicb.2017.01372

9,568 views
27 citations

Original Research

Published on 15 Aug 2022

Antibodies against the SARS-CoV-2 S1-RBD cross-react with dengue virus and hinder dengue pathogenesis

in Viral Immunology

Yi-Ling Cheng
Chiao-Hsuan Chao
Yen-Chung Lai
Kun-Han Hsieh
Jen-Ren Wang
Shu-Wen Wan
Hong-Jyun Huang
Yung-Chun Chuang
Woei-Jer Chuang
Trai-Ming Yeh

Frontiers in Immunology

doi 10.3389/fimmu.2022.941923

9,839 views
39 citations

Original Research

Published on 06 Aug 2018

Characterization of Dendritic Cell-Derived Extracellular Vesicles During Dengue Virus Infection

in Microbial Physiology and Metabolism

Sharon de T. Martins
Diogo Kuczera
Jan Lötvall
Juliano Bordignon
Lysangela R. Alves

Frontiers in Microbiology

doi 10.3389/fmicb.2018.01792

12,725 views
49 citations

Review

Published on 22 Oct 2020

Antibody-Dependent Enhancement: A Challenge for Developing a Safe Dengue Vaccine

in Virus and Host

Rahul Shukla
Viswanathan Ramasamy
Rajgokul K. Shanmugam
Richa Ahuja
Navin Khanna

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2020.572681

61,182 views
191 citations

Original Research

Published on 13 Aug 2025

Identification of Rhododendron mariae extraction as a new attachment inhibitor against dengue virus by targeting the envelope protein domain III

in Immunological Tolerance and Regulation

Chunyang Tian
Yuanru Zheng
Dongkai Tang
Haiyan Tian
Lingzhu Shi
Xuemei He
Jianhai Yu
Lijun Yan
Huihui Cao
Wei Zhao

Frontiers in Immunology

doi 10.3389/fimmu.2025.1663878

3,036 views

Original Research

Published on 09 Jan 2018

Pichia pastoris-Expressed Bivalent Virus-Like Particulate Vaccine Induces Domain III-Focused Bivalent Neutralizing Antibodies without Antibody-Dependent Enhancement in Vivo

in Virology

Rahul Shukla
Ravi K. Rajpoot
Upasana Arora
Ankur Poddar
Sathyamangalam Swaminathan
Navin Khanna

Frontiers in Microbiology

doi 10.3389/fmicb.2017.02644

10,719 views
34 citations

Articles

Prospective Artificial Intelligence to Dissect the Dengue Immune Response and Discover Therapeutics

Complexity of Human Antibody Response to Dengue Virus: Implication for Vaccine Development

Antibodies against the SARS-CoV-2 S1-RBD cross-react with dengue virus and hinder dengue pathogenesis

Characterization of Dendritic Cell-Derived Extracellular Vesicles During Dengue Virus Infection

Antibody-Dependent Enhancement: A Challenge for Developing a Safe Dengue Vaccine

Identification of Rhododendron mariae extraction as a new attachment inhibitor against dengue virus by targeting the envelope protein domain III

Pichia pastoris-Expressed Bivalent Virus-Like Particulate Vaccine Induces Domain III-Focused Bivalent Neutralizing Antibodies without Antibody-Dependent Enhancement in Vivo